Close

Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference Apr 2, 2024 06:59AM
Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference  Apr 11, 2023 07:30AM
Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference  Apr 11, 2023 07:30AM
Needham & Company Reiterates Buy Rating, $27 Price Target on Generation Bio (GBIO) May 6, 2022 05:53AM
Needham & Company Reiterates Generation Bio (GBIO) at Buy with $27 PT, "Technology Has Potential to Overcome Key Obstacles in Gene Therapy... Generation is a Potential Acquisition Target" Apr 12, 2022 06:17AM


Apr 5, 2022 07:30AM Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference
Apr 5, 2022 07:30AM Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference
Dec 15, 2021 07:10AM Generation Bio (GBIO) PT Lowered to $27 at Needham & Company
Apr 8, 2021 07:30AM Generation Bio to Present at 20th Annual Needham Virtual Healthcare Conference
Apr 8, 2021 07:30AM Generation Bio to Present at 20th Annual Needham Virtual Healthcare Conference
Feb 18, 2021 07:38AM Needham & Company Starts Generation Bio (GBIO) at Buy
Jan 5, 2021 09:30AM Pre-Open Stock Movers 01/05: (BPFH) (MRKR) (FUBO) Higher; (EGHT) (FATE) (VRAY) Lower (more...)